StocksDeepDive
Snapshot · DAX · generated 2026-10-15 11:33 UTC

FME.DE — Fresenius Medical Care AG

UNDERVALUED (MOS Model unreliable) · Quality 60/100

Price
39.17
Intrinsic value
160.21
Margin of safety
Model unreliable
Implied growth (reverse DCF)
-14.2%
model assumes +4.4%
Value Score
49.9
Quality
60
Psychology
6
Discovery
76
price/volume attention only
Moat score
48
erosion: none

Value Score: top 31% of DAX · Quality: bottom 31%

Dividend: 1.49/share (TTM) · yield 3.8% · payout 44%

Open the interactive Deep Dive for FME.DE →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/FME.DE - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is FME.DE undervalued?

As of 2026-10-15, FME.DE trades at 39.17 against a computed intrinsic value of 160.21 (+75.6% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Fresenius Medical Care AG's Value Score?

Fresenius Medical Care AG's Value Score is 49.9 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.

Does FME.DE pay a dividend?

Yes - FME.DE's trailing twelve-month dividend is 1.49/share, a yield of 3.8% at the current price (as of 2026-10-15).